Wall Street brokerages expect that Aetna (NYSE:AET) will post earnings of $3.12 per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Aetna’s earnings. The highest EPS estimate is $3.32 and the lowest is $2.94. Aetna reported earnings of $3.42 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 8.8%. The company is expected to announce its next earnings results on Thursday, August 2nd.
On average, analysts expect that Aetna will report full year earnings of $11.06 per share for the current fiscal year, with EPS estimates ranging from $10.80 to $11.50. For the next year, analysts expect that the company will post earnings of $12.22 per share, with EPS estimates ranging from $11.83 to $12.84. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that cover Aetna.
Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, May 1st. The company reported $3.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.97 by $0.22. The company had revenue of $15.34 billion during the quarter, compared to analysts’ expectations of $15.32 billion. Aetna had a return on equity of 21.42% and a net margin of 5.76%. The business’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.71 earnings per share.
A number of equities research analysts have recently commented on the company. Credit Suisse Group lifted their price objective on Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a research report on Wednesday, January 31st. Citigroup downgraded Aetna from a “buy” rating to a “neutral” rating and boosted their price target for the company from $187.89 to $212.00 in a research report on Wednesday, January 31st. Cowen reissued a “buy” rating and set a $212.00 price target on shares of Aetna in a research report on Tuesday, January 30th. Piper Jaffray Companies reissued a “buy” rating and set a $212.00 price target on shares of Aetna in a research report on Tuesday, January 30th. Finally, Deutsche Bank raised Aetna from a “hold” rating to a “buy” rating and boosted their price target for the company from $195.00 to $212.00 in a research report on Monday, January 22nd. Eight analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $196.36.
Several large investors have recently added to or reduced their stakes in the stock. Amalgamated Bank lifted its stake in shares of Aetna by 2.8% in the first quarter. Amalgamated Bank now owns 42,054 shares of the company’s stock worth $7,107,000 after acquiring an additional 1,151 shares in the last quarter. Summit Trail Advisors LLC lifted its stake in shares of Aetna by 591.8% in the first quarter. Summit Trail Advisors LLC now owns 20,008 shares of the company’s stock worth $1,617,000 after acquiring an additional 17,116 shares in the last quarter. WINTON GROUP Ltd lifted its stake in shares of Aetna by 3.6% in the first quarter. WINTON GROUP Ltd now owns 164,436 shares of the company’s stock worth $27,790,000 after acquiring an additional 5,672 shares in the last quarter. Levin Capital Strategies L.P. lifted its stake in shares of Aetna by 18.5% in the first quarter. Levin Capital Strategies L.P. now owns 13,385 shares of the company’s stock worth $2,262,000 after acquiring an additional 2,092 shares in the last quarter. Finally, CIBC World Markets Inc. lifted its stake in shares of Aetna by 219.3% in the first quarter. CIBC World Markets Inc. now owns 60,090 shares of the company’s stock worth $10,155,000 after acquiring an additional 41,271 shares in the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.
Shares of NYSE:AET traded down $0.51 during midday trading on Tuesday, reaching $177.21. The company’s stock had a trading volume of 2,348,000 shares, compared to its average volume of 2,394,661. The company has a market cap of $57.83 billion, a P/E ratio of 17.97, a P/E/G ratio of 1.49 and a beta of 0.64. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.47. Aetna has a 1 year low of $140.57 and a 1 year high of $194.40.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 1st. Shareholders of record on Wednesday, July 25th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Tuesday, July 24th. Aetna’s dividend payout ratio is presently 20.28%.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.